Effect of Dapsone gel 5% in the treatment of patients with acne vulgaris

Phase 3

Recruiting

• Conditions: Acne.; Acne vulgaris; L70.0

• Registration Number: IRCT20230806059062N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with moderate to severe inflammatory acne on the face

Exclusion Criteria

Pregnant and lactating women
History of using systemic anti-acne treatment drugs in the previous 1 month
The presence of inflammatory acne on the trunk without facial involvement
Cases of mild acne (the presence of only comedones without inflammatory lesions)
Photosensitivity
Patients receiving drugs that cause photosensitivity (such as griseofulvin).
Age above 30 years and below 12 years
Patients with G6pd deficiency (in the group receiving dapsone gel)
History of allergy to doxycycline, adapalene and dapsone

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acne severity based on the global acne grading system. Timepoint: Before starting treatment, 1, 2 and 3 months after starting treatment. Method of measurement: Global acne grading system.